Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
Abstract Bladder cancer (BC) is a heterogeneous disease that characterized by genomic instability and a high mutation rate. Heterogeneity in tumor may partially explain the diversity of responses to targeted therapies and the various clinical outcomes. A combination of cytology and cystoscopy is the...
Main Authors: | Hai‐Ming Huang, Hai‐Xia Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Cancer Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/cac2.12129 |
Similar Items
-
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
by: Marco Russano, et al.
Published: (2020-05-01) -
Circulating tumor DNA detection (liquid biopsy): prospects in oncology
by: N. V. Zhukov, et al.
Published: (2015-01-01) -
Circulating tumor DNA detection (liquid biopsy): prospects in oncology
by: N. V. Zhukov, et al.
Published: (2015-01-01) -
Plasma-Based Measurements of Tumor Heterogeneity Correlate with Clinical Outcomes in Metastatic Colorectal Cancer
by: Stephanie J. Yaung, et al.
Published: (2022-04-01) -
Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma
by: Andrew B Gill, et al.
Published: (2020-11-01)